Literature DB >> 2865152

Beta-blockers and sleep: a controlled trial.

T A Betts, C Alford.   

Abstract

The effects on sleep of four beta-blockers, atenolol, propranolol, metoprolol and pindolol, were studied in a placebo-controlled trial. Drugs were administered in random order to 10 female volunteers who acted as their own controls. Subjects were tested five times, each test period lasting 10 nights (2 baseline, 2 low dose, 4 high dose, and 2 withdrawal). A questionnaire concerning subjective appreciation of the quality of the previous night's sleep was completed each morning. Night recordings of muscle tension, eye movement, heart rate and electroencephalogram were recorded on paper and magnetic tape. Analysis of the subjective questionnaires showed that recollection of dreaming and awakening in the night was increased by the three lipophilic drugs, propranolol, metoprolol, and pindolol. These results confirm reports in the literature but are contrary to those expected from considering the effects of noradrenaline on sleep. Analysis of physiological records confirmed subjects' reports that waking was increased by the lipophilic drugs. Dreaming (rapid eye movement sleep, REM) was reduced, as predicted from knowledge of the effect of noradrenaline on sleep. Increased awakening leads to an increase in remembered dreaming which explains the otherwise paradoxical results. Although atenolol had no effect on subjective measures of sleep this hydrophilic drug also reduced REM frequency, suggesting that either it has some central effect, or that REM reduction is due to a peripheral 'shielding' effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865152     DOI: 10.1007/bf00543712

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  Atenolol and timolol.

Authors: 
Journal:  N Engl J Med       Date:  1982-11-18       Impact factor: 91.245

2.  Sleep studies in clinical pharmacology.

Authors:  I Oswald
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

3.  Propranolol in the treatment of narcolepsy.

Authors:  A Kales; C R Soldatos; R Cadieux; E O Bixler; T L Tan; M B Scharf
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

  3 in total
  20 in total

1.  Best practice guide for the treatment of nightmare disorder in adults.

Authors:  R Nisha Aurora; Rochelle S Zak; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Rama K Maganti; Kannan Ramar; David A Kristo; Sabin R Bista; Carin I Lamm; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

2.  Influence of cilazapril on memory functions and sleep behaviour in comparison with metoprolol and placebo in healthy subjects.

Authors:  B Dietrich; W M Herrmann
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 3.  Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.

Authors:  Philippe Yves Rémy Simon; Pierre-François Rousseau
Journal:  Can J Psychiatry       Date:  2016-07-19       Impact factor: 4.356

4.  Changing beta-blockers in heart failure: when is a class not a class?

Authors:  Jeffrey K Aronson
Journal:  Br J Gen Pract       Date:  2008-06       Impact factor: 5.386

Review 5.  Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia.

Authors:  Yuji Kadoi; Shigeru Saito
Journal:  J Anesth       Date:  2010-02       Impact factor: 2.078

6.  Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy.

Authors:  Y Yamada; F Shibuya; J Hamada; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

Review 7.  CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.

Authors:  W P Koella
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

Authors:  G S Nace; A J Wood
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

9.  Nonlinear distribution of atenolol between plasma and cerebrospinal fluid.

Authors:  F M Gengo; S C Fagan; L N Hopkins; D Wagner; D P Schuster
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

10.  The effects of captopril vs atenolol on memory, information processing and mood: a double-blind crossover study.

Authors:  I J Deary; S Capewell; C Hajducka; A L Muir
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.